98%
921
2 minutes
20
Purpose: To compare effectiveness of fornix- and limbal-based conjunctival flaps in trabeculectomy surgery.
Design: Systematic review.
Methods: Setting: CENTRAL, MEDLINE, LILACS, ISRCTN registry, ClinicalTrials.gov, WHO, and ICTRP were searched to identify eligible randomized controlled trials (RCTs).
Study Population: RCTs in which benefits and complications of fornix- vs limbal-based trabeculectomy for glaucoma were compared in adult glaucoma patients.
Observation Procedure: We followed Cochrane methodology for data extraction.
Main Outcome Measures: Proportion of failed trabeculectomies at 24 months, defined as the need for repeat surgery or uncontrolled intraocular pressure (IOP) >22 mm Hg, despite topical/systemic medications.
Results: The review included 6 trials with a total of 361 participants, showing no difference in effectiveness between fornix-based vs limbal-based trabeculectomy surgery, although with a high level of uncertainty owing to low event rates. In the fornix-based and limbal-based surgery, mean IOP at 12 months was similar, with ranges of 12.5-15.5 mm Hg and 11.7-15.1 mm Hg, respectively. Mean difference was 0.44 mm Hg (95% CI -0.45 to 1.33) and 0.86 mm Hg (95% CI -0.52 to 2.24) at 12 and 24 months of follow-up, respectively. Mean number of postoperative glaucoma medications was similar between the 2 groups. Mean difference was 0.02 (95% CI -0.15 to 0.19) at 12 months. As far as postoperative complications, an increased risk of shallow anterior chamber was observed in the limbal-based group.
Conclusion: Similar efficacy of trabeculectomy surgery with respect to bleb failure or IOP control was observed in both types of conjunctival flap incisions. A significant difference was detected in the risk of postoperative shallow anterior chamber, which was increased in the limbal-based group.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321540 | PMC |
http://dx.doi.org/10.1016/j.ajo.2016.10.006 | DOI Listing |
Exp Eye Res
April 2023
Kocaeli Seka State Hospital, Department of Ophthalmology, Kocaeli, Turkey. Electronic address:
Purpose: To investigate the efficacy of nintedanib on preventing postoperative scar in formation following glaucoma filtering surgery (GFC) in rabbits in comparison with Mitomycin-C (MMC).
Design: Experimental Animal Study.
Methods: 24 New Zealand rabbits were divided randomly into 3 groups as Sham, Nindetanib and MMC(n = 8).
Clin Ophthalmol
November 2022
Department of Ophthalmology, Nippon Medical School, Tokyo, Japan.
Purpose: To objectively evaluate surgically induced astigmatism (SIA) after trabeculectomy with mitomycin C and investigate the relationships between SIA and various factors.
Patients And Methods: This retrospective study included the right eyes of 66 consecutive patients who underwent standard trabeculectomy performed in the superior temporal quadrant for the first time by a single surgeon. Keratometry recordings made before surgery and 3 months after surgery were collected to calculate the SIA in each patient.
Indian J Ophthalmol
April 2022
Department of Paediatric Ophthalmology and Strabismus, Aravind Eye Hospital, Madurai, Tamil Nadu, India.
Background: Detaching a rectus muscle irreparably destroys its ciliary artery circulation which also supplies the anterior segment of the eye.
Purpose: To educate strabismus surgeons about a method of detaching a muscle without compromising anterior segment circulation.
Synopsis: A limbal based conjunctival incision is made.
Eur J Ophthalmol
November 2022
Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, 12810Hokkaido University; Sapporo, Japan.
Background: Cyclodialysis cleft is an uncommon finding due to blunt ocular trauma. A larger and more chronic cyclodialysis requires surgical repair. The aim of this study was to introduce a minimally invasive suturing technique for the lens-sparing repair of traumatic cyclodialysis cleft and evaluate outcomes.
View Article and Find Full Text PDFCochrane Database Syst Rev
August 2021
Department of Ophthalmology and Visual Sciences, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Background: Glaucoma is one of the leading largely preventable causes of blindness in the world. It is usually addressed first medically with topical intraocular pressure-lowering drops or by laser trabeculoplasty. In cases where such treatment fails, glaucoma-filtering surgery such as trabeculectomy, is commonly considered.
View Article and Find Full Text PDF